Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Battery X Metals Announces Exercise of Call Right to Acquire All Remaining Shares of Lithium-Ion Battery Diagnostics and Rebalancing Technology Company

In This Article:

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

VANCOUVER, BC / ACCESS Newswire / March 20, 2025 / Battery X Metals Inc. (CSE:BATX)(OTCQB:BATXF)(FSE:R0W, WKN:A3EMJB)("Battery X Metals" or the "Company") an energy transition resource exploration and technology company, announces that, further to the Company's news release dated June 6, 2024, and pursuant to the terms of the share exchange agreement referenced therein, dated April 10, 2024, as amended and restated on May 1, 2024, and further amended on May 31, 2024 (collectively, the "Share Exchange Agreement"), it has exercised its call right (the "Call Right") to acquire the remaining 51% of the common shares of Li-ion Battery Renewable Technologies Inc. ("LIBRT") from the LIBRT shareholders in consideration for approximately 3,030,296 common shares (the "Shares") of the Company (as adjusted for the Company's 3.3:1 share consolidation dated December 10, 2024) (the "Acquisition"). The exercise of the Call Right and the Acquisition are subject to compliance with the policies of the Canadian Securities Exchange (the "CSE"). No finder's fees are payable in connection with the Acquisition.

On closing of the Share Exchange Agreement, the Company, the LIBRT shareholders, and LIBRT entered into a shareholders' agreement dated June 6, 2024 (the "Shareholders Agreement"), pursuant to which the Company was granted the Call Right. Following the exercise of the Call Right, the Acquisition is subject to a five day comment period in accordance with the policies of the CSE, after which the Company intends to close the Acquisition.

Since acquiring its initial 49% interest in 2024, as disclosed in the Company's news releases dated September 27, 2024, and October 2, 2024, LIBRT has reached key milestones in technology development, strengthened its partnership with Beijing Pengneng Science & Technology Ltd. through a Second Amended Agreement, and made significant progress in the design, development, and production of its Diagnostic and Rebalancing Machine Prototype 2.0, which is scheduled for delivery in April 2025. Additionally, LIBRT has engaged a leading patent law firm to file provisional patents for its lithium-ion battery diagnostic and rebalancing technology. In light of these advancements and ongoing progress, the Company is actively pursuing the consolidation of its interest in LIBRT by acquiring all remaining outstanding shares.